Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India
Drugs Controller General of India (DCGI) Dr VG Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while...
Comments
Post a Comment